Cardiovascular Pharmacology

He is currently working as deputy director for Institute of Regenerative Medicine and Biotherapy (IRMB) composed of a 150 persons. He is also a leader of a INSERM research team and Director of a stem cell facility CHU (SAFE-iPSC) comprising more than 33 persons. He is mentoring 8 senior scientists (CR1, MCU, MCU/PH), 11 Ph.D. students and 3 Post-Docs, 9 technicians and engineers. Also he is an invited speaker in 48 national and international conferences and seminars in France and abroad in the last 5 years (3 plenary lectures).

To explore epigenetic mechanisms involved in senescence/aging impairing stem cell renewal and reprogramming, which is of major importance aging with outcomes in regenerative medicine and cell therapies.

Nader G. Abraham is working as professor in Newyork Medical College, Newyork

Pharmacology

Essam Abdel-Sattar is currently working as professor in Cairo University, Egypt

Quality control of drugs

Dr. Yukio Yoneda is a Professor Emeritus in Kanazawa University, where he worked as a Chairman Professor of Pharmacology from 1999 to 2015. He graduated from Osaka University, Faculty of Pharmaceutical Sciences in 1972, followed by appointments in Kyoto Prefectural University of Medicine, City of Hope Research Institute, CA, USA and Setsunan University. He is serving as an Associate Editor in several international journals such as Neurochemistry International, Neurochemical Research and Journal of Neuroscience Research, in addition to acting on the Editorial Board in other international scientific journals. His research interests have been lying on pharmacological profiling of amino acid signaling in neuronal and non-neuronal cells using molecular biological techniques. As a return of laboratory experimental results to the community, he is now attempting to develop several dietary supplements beneficial for the prophylaxis of different diseases besides the bench work with colleagues in domestic and foreign universities.

Molecular pharmacology of amino acid signaling in neuronal and non-neuronal cells

She is currently working as Vice Dean for Academics, Student Affairs, and Cooperation, Postgraduate School, Universitas Padjadjaran, Indonesia. Also she is a professor in the Department of Pharmacology and Clinical Pharmacy in the same university.She is the editor/reviewer of many journals and she has won many awards.

Pharmacology

Stefan Glück, MD, PhD is a Medical Oncologist with focus on solid tumors including brain cancer activities worldwide. Additionally, he is responsible for Immuno-Oncology programs in solid tumors and hematologic diseases and is in the area of Early Assets. He completed his medical studies at the University of West Berlin, Germany in 1978 followed by a medical oncology & bone marrow transplant fellowship in Toronto, Canada. Before becoming V.P. of Global Medical Affairs at Celgene Corp., he previously served as Sylvester Professor of Medicine at the Miller School of Medicine in Miami, Florida until 2014. From 2009-2010 he was Assistant Director of the Sylvester Comprehensive Cancer Center & Associate Chief, for the Division of Hematology & Medical Oncology and from 2003-2008 he served as Clinical Director of the Braman Family Breast Cancer Institute in Miami, Florida. He has authored and co-authored over 260 articles, and has written more than 350 papers at national and international meetings.

Medical Oncology

Damien Byas is the President, North American Scientific Committee on Cardiovascular Health, USA as well as an Epidemiologist and Professor of Public Health, American Public Health Association, International Public Health Delegate, USA.

Cardiology, Cardiovascular Diseases, Epidemiology

Aris Lacis, cardiac surgeon, professor, MD, PhD graduated Riga Medical Institute in 1961. General and thoracic surgeon in P. Stradina University Hospital in Riga (1964–1969). Thoracic and cardiac surgeon in the Latvian Centre for Cardiovascular Surgery (1969–1994). Since 1994 until 2012 – the head of Pediatric Cardiology and Cardiac Surgery Clinic in University Children’s Hospital, Riga; since 2012 – a consulting professor of this Clinic. Vicepresident of Latvian Society for Cardiovascular Surgery. President of Latvian Association for Pediatric Cardiologists. Author of 395 scientific publications, 3 monographs and 13 patents. Investigator in more than 10 clinical trials including cardiosurgical procedures performed under deep hypothermia, hybrid procedures etc. In May 2009 have been used transcutan intramyocardial delivery techniques for treatment (idiopathic dilated cardiomyopathia) the first 3 months aged patient in the world with autologous bone marrow derived progenitor cells. In November 2010 the first patient with end stage pulmonary hypertension received intrapulmonary implantation autologous stem cells.

Pediatric Cardiology, Cardiovascular Surgery

Michiaki Nagai has completed his graduation from the Jichi Medical University School of Medicine and has been engaged in the Cardiovascular Medicine. Using volumetric analysis in MR SPGR imaging, he has been investigating the fields for target hypertensive organ damages including the relationships among hypertension, blood pressure variability, brain atrophy, cognitive impairment and central autonomic nervous system including the insular cortex. He was engaged in the Interventional Cardiology at Hiroshima City Asa Hospital as the Vice Director. He won the Japanese Society of Hypertension Award in the International Society of Hypertension 2006, the Young Investigator’s Award in the 8th Japanese Neurocardiology Workshop 2007 and Young Scientist Award in the second annual scientific forum of clinical hypertension of the Japanese Society of Hypertension 2013.

Hypertension, Interventional Cardiology, Cardiovascular Medicine

Mary Shibuya is an experienced native English medical editor/writer of 32 years living in Japan with a background in chemistry and allergy research at Mayo Clinic (Rochester, MN). For 23 years she was the language editor of the journal Internal Medicine, published by the Japanese Society of Internal Medicine. In addition to editing and preparing research articles for publication in international journals, she attended various medical/scientific congresses as Press (interviews, transcription, summarizing). She also enjoys lecturing on scientific medical writing in English to graduate schools and pharmaceutical companies. She strives to encourage ESL doctors/researchers to publish in English.

Allergy research,chemistry,scientific medical writing

She was born in Zagreb. In 1972, she graduated from the School of Medicine in Zagreb.In 1980 she completed her specialisation in internal medicine at the Department for Heart and Blood Vessel Diseases, Zagreb University Hospital Centre. She continued cardiology training in Stockholm, Uppsala and Pisa. She was the first person in Croatia to introduce and conduct the stress echocardiography method (1992) and has published 56 scientific and academic papers, primarily in the field of cardiology. By 2001, she had been working as an internist cardiologist specialist and chief of the Polyclinic Section at the Department for the Prevention of Cardiovascular Diseases and Rehabilitation in Zagreb. In 2002, she founded the Saint Nicholas Polyclinic for Cardiovascular Diseases and Prevention on Korčula. She is a member of the Croatian Association of Physicians, the Croatian Cardiologic Association, European Cardiologic Association, European Association of Cardiac Decompensation (HFA), European Association for Echocardiography (EAE), and the New York Academy of Sciences. She holds the Homeland Appreciation Memorial.

Cardiovascular Diseases and Prevention

Galya Naydenova Atanasova completed her Ph.D. training in Cardiology from Department of Cardiology, Pulmonology and Endocrinology at Pleven Medical University, Bulgaria. She is a Cardiologist, Assistant Professor at the Department of Internal Medicine, Medical University, Pleven. She is a General Practitioner in Pleven. She specialized in Cardiology from Pleven Medical University during 2015, and General Medicine from Pleven Medical University, Bulgaria during 1993. She has attended to many International Events and presented her research work. She did many researches on metabolic syndrome and myocardial infarction of heart.

metabolic syndrome and myocardial infarction of heart